PERICOLINI, Eva
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.746
AS - Asia 7.341
EU - Europa 6.869
SA - Sud America 1.052
Continente sconosciuto - Info sul continente non disponibili 286
AF - Africa 202
OC - Oceania 56
Totale 32.552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.281
SG - Singapore 2.231
IT - Italia 1.970
GB - Regno Unito 1.848
CN - Cina 1.685
HK - Hong Kong 825
BR - Brasile 752
VN - Vietnam 712
DE - Germania 557
SE - Svezia 502
BD - Bangladesh 419
RU - Federazione Russa 287
FR - Francia 284
UA - Ucraina 260
FI - Finlandia 256
IN - India 239
KR - Corea 238
TR - Turchia 232
CA - Canada 214
ID - Indonesia 203
PL - Polonia 162
BG - Bulgaria 121
MX - Messico 114
AR - Argentina 94
IQ - Iraq 81
RO - Romania 81
NL - Olanda 75
JP - Giappone 73
BE - Belgio 65
ZA - Sudafrica 65
ES - Italia 50
IE - Irlanda 50
MY - Malesia 49
EC - Ecuador 48
LT - Lituania 46
PK - Pakistan 46
HU - Ungheria 45
AE - Emirati Arabi Uniti 44
AU - Australia 44
CL - Cile 44
CO - Colombia 43
AT - Austria 41
IR - Iran 39
PT - Portogallo 31
EG - Egitto 29
MA - Marocco 27
CH - Svizzera 26
TH - Thailandia 26
PE - Perù 25
PH - Filippine 25
UZ - Uzbekistan 25
CR - Costa Rica 22
IL - Israele 22
NO - Norvegia 22
JM - Giamaica 20
VE - Venezuela 20
DZ - Algeria 18
CZ - Repubblica Ceca 17
PY - Paraguay 16
SA - Arabia Saudita 16
TW - Taiwan 16
HN - Honduras 14
AZ - Azerbaigian 12
GR - Grecia 12
KE - Kenya 12
NP - Nepal 12
DO - Repubblica Dominicana 11
JO - Giordania 11
TN - Tunisia 11
DK - Danimarca 10
GT - Guatemala 10
NZ - Nuova Zelanda 10
PR - Porto Rico 10
SV - El Salvador 10
BB - Barbados 9
TT - Trinidad e Tobago 9
EE - Estonia 8
KW - Kuwait 8
OM - Oman 8
SK - Slovacchia (Repubblica Slovacca) 8
GP - Guadalupe 7
BO - Bolivia 6
CW - ???statistics.table.value.countryCode.CW??? 6
ET - Etiopia 6
LB - Libano 6
LV - Lettonia 6
PA - Panama 6
UG - Uganda 6
KG - Kirghizistan 5
QA - Qatar 5
RS - Serbia 5
XK - ???statistics.table.value.countryCode.XK??? 5
AL - Albania 4
CG - Congo 4
CI - Costa d'Avorio 4
LK - Sri Lanka 4
MT - Malta 4
NG - Nigeria 4
SI - Slovenia 4
BA - Bosnia-Erzegovina 3
Totale 32.213
Salva come PNG Salva come JPEG
Città #
Ashburn 1.795
Singapore 1.587
Santa Clara 1.584
Fairfield 1.343
Southend 1.065
San Jose 958
Council Bluffs 835
Woodbridge 789
Hong Kong 783
Chandler 631
Houston 578
Seattle 499
Wilmington 425
Jacksonville 392
Hefei 383
Cambridge 382
Dearborn 380
Beijing 378
London 321
Ann Arbor 311
Modena 263
Nyköping 262
Los Angeles 256
New York 245
Ho Chi Minh City 217
Seoul 202
Milan 163
The Dalles 162
Hanoi 159
Helsinki 151
Dallas 140
Jakarta 138
San Diego 123
Buffalo 121
Sofia 113
Chicago 110
Princeton 103
Kraków 101
Bremen 99
Lauterbourg 99
Bologna 97
Columbus 94
Eugene 91
Rome 90
Moscow 83
São Paulo 77
Redwood City 76
Orem 75
Izmir 64
Boardman 63
Tokyo 62
Chennai 57
Timisoara 57
Carpi 56
Reggio Emilia 56
Shanghai 55
Atlanta 54
Exeter 54
Phoenix 53
Nuremberg 50
Toronto 46
Montreal 43
Haiphong 42
Munich 42
Warsaw 42
Guangzhou 41
Frankfurt am Main 40
Johannesburg 40
Denver 39
Mexico City 39
Da Nang 38
Nanjing 38
Parma 38
Brooklyn 37
Dublin 37
San Francisco 34
Verona 33
Dong Ket 32
Brussels 31
Porto Alegre 30
Salt Lake City 30
Baghdad 28
Mumbai 28
Naples 28
Perugia 28
Boston 26
Stockholm 26
Amsterdam 25
Florence 25
Trieste 25
Norwalk 24
Poplar 24
Dongguan 23
Falls Church 23
Rio de Janeiro 23
Kent 22
Springfield 22
Turin 22
Lappeenranta 21
Basingstoke 20
Totale 21.265
Salva come PNG Salva come JPEG
Nome #
Zinc treatment prevents neutrophil recruitment and inflammation by blocking Candida albicans Pra1 during vulvovaginal candidiasis. 951
Evaluation of benzydamine effects on Candida albicans adhesion, biofilm formation and persistence onto abiotic surfaces 500
Induction of caspase-11 by aspartyl proteinases of Candida albicans and implication in promoting inflammatory response 490
Pomegranate extract affects fungal biofilm production: consumption of phenolic compounds and alteration of fungal autoinducers release 452
Bacillus coagulans LMG S-24828 Impairs Candida Virulence and Protects Vaginal Epithelial Cells against Candida Infection In Vitro 416
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 409
Genomic and phenotypic variation in morphogenetic networks of two Candida albicans isolates subtends their different pathogenic potential 404
In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity. 398
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 393
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 375
Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro 371
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 367
Antibody Constant Region Peptides Can Display Immunomodulatory Activity through Activation of the Dectin-1 Signalling Pathway 366
Effects of Cupral® on the formation and persistence of microbial biofilms in vitro 356
Effects of different mouthwashes on biofilm formation by oral streptococci 353
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 345
In vitro analysis of epithelial tolerability and anti-Candida effect of a new lactic acid-based vaginal gel formulation 338
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis- Associated Strains 333
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 333
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 330
A Purified Capsular Polysaccharide Markedly Inhibits Inflammatory Response during Endotoxic Shock 326
Effects of different mouthwashes on Candida albicans adhesion, susceptibility to phagocytic cells and capacity to elicit pro-inflammatory cytokine response 325
Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration 325
Antimicrobial and antibiofilm efficacy of a copper/calcium hydroxide-based endodontic paste against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans 325
Antibacterial Effects of MicroRepair®BIOMA-Based Toothpaste and Chewing Gum on Orthodontic Elastics Contaminated In Vitro with Saliva from Healthy Donors: A Pilot Study 324
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 322
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 319
Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity 315
Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis 312
Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice 302
Anti-Candida and Anti-Inflammatory Properties of a Vaginal Gel Formulation: Novel Data Concerning Vaginal Infection and Dysbiosis 301
Mouse Strain-Dependent Differences in Estrogen Sensitivity During Vaginal Candidiasis 299
A microbial polysaccharide reduces the severity of rheumatoid arthritis by influencing Th17 differentiation and proinflammatory cytokines production 297
Hyphal morphology, molecular genetics and phylogenetic relationships among commensal and pathogenic vulvovaginal isolates of Candida albicans 294
Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis 284
Effects of benzydamine and mouthwashes containing benzydamine on Candida albicans adhesion, biofilm formation, regrowth, and persistence 281
The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection 280
Functional Improvement of Regulatory T Cells From Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan 279
Secretory aspartyl-proteinases of Candida albicans contribute to severe inflammation observed in the course of vaginal candidiasis 279
A novel bioluminescence mouse model for monitoring oropharyngeal candidiasis in mice 270
The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients 270
Role of CD45 signaling pathway in Galactoxylomannan-induced T cell damage 265
Modulation of phenotype and function of dendritic cells by a therapeutic synthetic killer peptide. 264
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 264
Inflammatory response during human vaginal infection with Candida albicans 263
Peptides of the constant region of antibodies display fungicidal activity 263
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 263
Saccharomyces cerevisiae as a new therapeutic agent against oropharyngeal candidiasis 258
Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin A1 expression 257
NLRP3 inflammasome is a key player in human vulvovaginal disease caused by Candida albicans 257
Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration. 257
An Untargeted Metabolomic Analysis of Lacticaseibacillus (L.) rhamnosus, Lactobacillus (L.) acidophilus, Lactiplantibacillus (L.) plantarum and Limosilactobacillus (L.) reuteri Reveals an Upregulated Production of Inosine from L. rhamnosus 256
Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy 254
A microbial polysaccharide promotes selective elimination of pathogenic T cells from peripheral blood of rheumatoid arthritis patients by apoptosis induction. 252
Experimental models of vaginal candidiasis and inflammation 249
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis 246
The Candida albicans Pra1 zincophore promotes neutrophils recruitment and inflammation during vulvovaginal candidiasis 244
Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection 243
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis 243
A role for secretory aspartyl proteinase of Candida albicans in mouse vaginal inflammation and vaginal candidiasis 242
GILZ restrains neutrophil activation by inhibiting the MAPK pathway 240
Comparative analysis of commensal and pathogenic vulvovaginal clinical isolates of Candida albicans: hyphal morphology, molecular genetics and phylogenetic relationships 240
THE PROTECTIVE ROLE OF TYPE-I INTERFERONS AXIS ACTIVATION IN THE VULVOVAGINAL CANDIDIASIS MODEL 236
It takes two to tango: how a dysregulation of the innate immunity, coupled with Candida virulence, triggers VVC onset 234
Cryptococcus neoformans capsular polysaccharide component Galactoxylomannan induces apoptosis of human T cells through activation of Caspase-8 231
Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro 230
EDTA and Taurolidine affect Pseudomonas aeruginosa virulence in vitro: impairment of secretory profile and biofilm production onto peritoneal dialysis catheters 229
Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection 225
Involvement of glycoreceptors in galactoxylomannan-induced T cell death 225
Aspartyl proteinases of Candida albicans induce caspase-11: implication in promoting inflammatory response 223
Elucidating the immunological function of the Cryptococcus neoformans capsule 221
Functional defect of natural immune system in an apparent immunocompetent patient with pulmonary cryptococcosis 220
Aspartyl proteinases of Candida albicans induce caspase-11: implication in promoting inflammatory response. 219
A role for Cryptococcus neoformans galactoxylomannan in T cell apoptosis and function. 219
Chronic vaginal candidiasis is achievable in outbred CD-1 mice 219
New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges 217
Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome 214
Gray phenotype: enhanced fitness strategy for Candida dubliniensis 213
A new strategy to prevent biofilm and clot formation in medical devices: the use of atmospheric non-thermal plasma assisted deposition of silver-based nanostructured coatings 212
Indinavir influences biological function of dendritic cells and stimulates antifungal immunity 212
A microbial polysaccharide reduces the severity of rheumatoid arthtritis via inhibition of Th17 differentiation 210
Indinavir-treated Cryptococcus neoformans promotes an efficient antifungal immune response in immunosuppressed hosts 209
Microbial immune suppression mediated by direct engagement of inhibitory Fc receptor 208
Secretory aspartyl-proteinases of Candida albicans contribute to severe inflammation observed in the course of vaginal candidiasis 207
In vivo induction of neutrophils chemotaxis by secretory aspartyl proteinases of Candida albicans 206
Candidalysin is a key player in activating vaginal cell ROS in an in vitro infection model 205
The GITRL-GITR system alters TLR-4 expression on DC during fungal infection 204
Any antibody fragment might exert antifungal activity 203
Therapeutic activity of Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis 203
Immunomodulatory properties of heat-inactivated biomasses by selected bacterial and fungal species included in the Qualified Presumption of Safety list of the European Food Safety Authority 202
The Propionibacterium spp. extract reduces Candida albicans-induced damage to vaginal epithelial cells and increases mitochondrial response to Candida albicans infection in vitro 202
Evaluation of Anti-Candida Activity of Vitis vinifera L. Seed Extracts Obtained from Wine and Table Cultivars 201
Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages 201
Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages 199
Cell-Free Supernatant from a Strain of Bacillus siamensis Isolated from the Skin Showed a Broad Spectrum of Antimicrobial Activity 194
The pathogenic and colonization potential of Candida africana 192
Vaginal Clinical Isolates of Candida albicans Differentially Modulate Complosome Activation in Vaginal Epithelial Cells 190
Cutibacterium acnes lysate improves cellular response against Candida albicans, Escherichia coli and Gardnerella vaginalis in an in vitro model of vaginal infection 189
In vivo colonization and pathogenic potential of C. africana 189
Comparison between bioluminescence imaging technique and CFU count for the study of oropharyngeal candidiasis in mice 188
Totale 27.930
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.323 0 0 0 91 46 98 103 92 197 166 330 200
2022/20232.193 181 161 202 203 293 272 67 212 298 62 122 120
2023/20241.961 80 124 147 123 244 251 142 252 73 163 149 213
2024/20255.335 200 120 127 394 1.165 850 266 365 519 383 430 516
2025/20269.851 542 380 572 1.171 1.275 706 1.168 559 935 1.071 879 593
2026/20273.329 674 809 904 942 0 0 0 0 0 0 0 0
Totale 32.552